FDA inspection

Aspire Pharmaceuticals, Inc.: FDA inspection ending Mar 21, 2006

FDA inspection 420344 · Voluntary Action Indicated (VAI) · Somerset, NJ

Key facts

Inspection ID 420344
Firm Aspire Pharmaceuticals, Inc.
FEI number 3003159106
Address 37 & 41 Veronica Ave
City Somerset
State NJ
ZIP 08873-6800
Fiscal year 2006
Inspection end date Mar 21, 2006
Classification Voluntary Action Indicated (VAI)
Project area Foodborne Biological Hazard
Product type Food/Cosmetics

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections